首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1935152

气喘治疗市场按药物类别、给药途径、通路和地区划分

Asthma Therapeutics Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年01月30日 | 出版商:

Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2026 年，气喘药物市值将达到 204.4 亿美元，到 2033 年将达到 233 亿美元，2026 年至 2033 年的年复合成长率（CAGR）为 1.9%。

报告内容		报告详情
基准年：	2025	2026年市场规模：	204.4亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
预测期（2026-2033年）复合年增长率：	1.90%	2033 年的预测值：	233亿美元

气喘是一种慢性发炎性疾病，会导致肺部气道发炎和狭窄。其特征是多种症状，气喘气道内壁肿胀和发炎、咳嗽、呼吸急促和胸闷。气喘分为多种类型，包括过敏性气喘、非过敏性气喘、成人起病型气喘、运动性气喘（在运动过程中发生）、夜间气喘和职业性气喘。夜间气喘也称为夜间气喘。由于它是一种非常严重的气喘类型，因此正确的诊断和治疗至关重要。

市场动态

主要企业不断推出新型雾化器产品，预计将推动全球气喘药物市场成长。例如，2018年10月，皇家飞利浦公司宣布在北美推出其新型网状雾化器「InnoSpire Go」。本产品用于治疗包括气喘在内的呼吸系统疾病。它是一款便携式手持雾化器系统，可实现快速治疗，仅需四分钟即可完成药物输送。 InnoSpire Go 适用于成人和儿童。

然而，产品召回是限制气喘药物市场成长的主要因素，预计会阻碍市场成长。例如，2018年8月，美国食品药物管理局（FDA）发布了针对Camber Pharmaceuticals公司生产的Montelukast sodium锭的召回警报。召回原因是Montelukast sodium片的瓶子里装错了药物（氯沙坦钾片）。

本次调查的主要特点

本报告以 2025 年为基准年，对全球气喘药物市场规模（十亿美元）和预测期（2026-2033 年）的复合年增长率（%）进行了详细分析。
该报告重点介绍了各个细分市场的潜在商机，并为该市场说明了一个有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本报告根据以下参数介绍了全球气喘药物市场主要企业的概况：公司概况、财务表现、产品系列、地理扩张、分销策略、主要发展和策略。
本报告的研究结果将使企业负责人和经营团队能够就未来的产品发布、政府措施、技术升级、市场扩张和行销策略做出明智的决策。
这份全球气喘药物市场报告将为行业内的各种相关人员提供有价值的信息，包括投资者、产品製造商、经销商、供应商、研究和咨询公司、新参与企业和金融分析师。

北美洲
- 我们。
- 加拿大
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 日本
- 印度
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲国家
非洲
- 北非
- 中非
- 南非
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家

第八章竞争情势

热图分析
公司简介
- GlaxoSmithKline Plc.
- Philips Healthcare
- AstraZeneca Plc.
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim GmbH
- Sanofi-Aventis SA
- CareFusion Corporation
- Sunovion Pharmaceutical Ltd.
- Merck &Co. Inc.
- Roche Diagnostics

第九章各节

参考
调查方法

简介目录

Product Code: CMI2698

Asthma Therapeutics Market is estimated to be valued at USD 20.44 Bn in 2026 and is expected to reach USD 23.30 Bn by 2033, growing at a compound annual growth rate (CAGR) of 1.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 20.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	1.90%	2033 Value Projection:	USD 23.30 Bn

Asthma is a long-term inflammatory disease that causes inflammation and narrowing of the airways in the lung. It is characterized by various symptoms such as swelling or inflammation in the airways linings, coughing, shortness of breath, and tightness of chest. Asthma is classified into many different types including allergic asthma, non-allergic asthma, adult onset asthma, exercised induced asthma (that occurs with physical exertion), nocturnal asthma, and occupational asthma. Nocturnal is also known as the nighttime asthma. It is very serious type of asthma therefore, it needs a proper diagnosis and treatment.

Market Dynamics

Increasing launches of nebulizer by key players is expected to propel global asthma therapeutics market growth. For instance, in October 2018, Koninklijke Philips N.V. announced launch of its new mesh nebulizer, InnoSpire Go, in North America. This is used for the treatment of respiratory diseases including asthma. It is portable, hand-held nebulizer system, which is short time treatment. It delivers the medicine in just four minutes. InnoSpire Go designed for both adults and children.

However, product recall is major restraining factor for asthma therapeutics market growth, which is expected to hamper the market growth. For instance, in August 2018, Camber Pharmaceuticals were issued product recall alert from U.S. Food and Drug Administration for its Montelukast Sodium Tablets. These tablets are recalled because Montelukast Sodium Tablet bottles contain wrong medicine (Losartan Potassium Tablet).

Key features of the study

This report provides in-depth analysis of the global asthma therapeutics market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 - 2033, considering 2025, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global asthma therapeutics market based on the following parameters-company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc. Merck & Co., Inc., and Roche Diagnostics.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for global asthma therapeutics market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
- Corticosteroids
- Beta2-Agonists (Long-Acting and Short-Acting)
- Leukotriene Inhibitors
- Long-Acting Muscarinic Antagonists (LAMA)
- Interleukin Antagonists
- Anti-Immunoglobulin E (IgE) Agents
- Combination Products
- Others
Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
- Oral, Inhalation
- Injection
Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline Plc.
- Philips Healthcare
- AstraZeneca Plc.
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim GmbH,
- Sanofi-Aventis SA
- CareFusion Corporation
- Sunovion Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Roche Diagnostics

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technology Advancements
Epidemiology
Product Recalls
Government Initiatives
Historical Overview
Merger and Acquisition
Regulatory and Reimbursement Scenario
PORTER'S Five Forces
PEST Analysis

4. Global Asthma Therapeutics Market, By Drug Class, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Corticosteroids
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Beta2-Agonists (Long-Acting and Short-Acting)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Leukotriene Inhibitors
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Long-Acting Muscarinic Antagonists (LAMA)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Interleukin Antagonists
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Anti-Immunoglobulin E (IgE) Agents
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Combination Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Asthma Therapeutics Market, By Route of Administration, 2026-2033, (USD Bn)

Oral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Inhalation
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Injection
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Asthma Therapeutics Market, By Distribution Chanel, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Asthma Therapeutics Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - US.
  - Canada
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - UK.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Africa
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- GlaxoSmithKline Plc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Philips Healthcare
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- AstraZeneca Plc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sanofi- Aventis SA
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- CareFusion Corporation
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sunovion Pharmaceutical Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Merck & Co. Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Roche Diagnostics
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

气喘治疗市场按药物类别、给药途径、通路和地区划分

Asthma Therapeutics Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

市场动态